Phase II-b randomized double-blind placebo-controlled trial of lactobacillus crispatus CTV-05 (lactin-v) to prevent the recurrence of bacterial vaginosis.
Ended Awarded Last action
- Contract number
- HHSN27200007
- Awardee
-
Social & Scientific Systems, Inc. UEI XKMBEM2BTLK3 Part of DLH Holdings Corp
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,895,668
Award facts
- Contract value 100% obligated
- $4,895,668.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Silver Spring, MD 20910, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$104,263 | |
| Funding Only Action | -$51,780 | |
| Funding Only Action | -$175,332 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $408,177 | |
| Funding Only Action | $821,977 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $1,811,664 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $2,185,224 |
Show all 12
About this award
This federal contract award, with a ceiling value of $4,895,668.27, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Social & Scientific Systems, Inc., a subsidiary of DLH Holdings Corp. The contract supports a Phase II-b randomized, double-blind, placebo-controlled trial to evaluate the use of Lactobacillus Crispatus CTV-05 (LACTIN-V) to prevent the recurrence of bacterial vaginosis. The contract does not have a set-aside designation.
Social & Scientific Systems, Inc. has subcontracted with several entities to provide oversight, implementation, and laboratory support for the clinical trial, including the University of California, San Diego; the State of California Controller's Office; the University of Washington; the Regents of the University of California, San Francisco; the University of California, San Diego; and the Magee-Womens Research Institute And Foundation. This contract is part of NIAID's broader research efforts to develop new treatments and prevention strategies for infectious diseases.
Quick answers
Who was awarded contract HHSN27200007?
HHSN27200007 was awarded to Social & Scientific Systems, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 28, 2015.
How much is contract HHSN27200007 worth?
The government has obligated $4,895,668 on HHSN27200007.
Is contract HHSN27200007 an order under another contract?
Yes. HHSN27200007 is a delivery order under HHSN272201300014I, an indefinite delivery contract.
Was contract HHSN27200007 competed?
The extent of competition for HHSN27200007 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award